bifendate has been researched along with glycyrrhizic acid in 1 studies
Studies (bifendate) | Trials (bifendate) | Recent Studies (post-2010) (bifendate) | Studies (glycyrrhizic acid) | Trials (glycyrrhizic acid) | Recent Studies (post-2010) (glycyrrhizic acid) |
---|---|---|---|---|---|
124 | 8 | 43 | 2,079 | 70 | 1,068 |
Protein | Taxonomy | bifendate (IC50) | glycyrrhizic acid (IC50) |
---|---|---|---|
Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 0.0115 | |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | 0.0135 | |
Corticosteroid 11-beta-dehydrogenase isozyme 2 | Homo sapiens (human) | 0.0007 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, S; Han, J; Jin, S; Lu, Y; Lv, Q; Qi, J; Wu, W; Yuan, H | 1 |
1 other study(ies) available for bifendate and glycyrrhizic acid
Article | Year |
---|---|
Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.
Topics: Administration, Oral; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Biological Availability; Biphenyl Compounds; Carbon Tetrachloride; Deoxycholic Acid; Disease Models, Animal; Drug Stability; Glycyrrhizic Acid; Liver; Male; Micelles; Nanoconjugates; Particle Size; Phospholipids; Rats; Rats, Wistar; Surface Properties | 2012 |